EpiSwitch PSE vs. PSA: Don't Spend $900 on This Test Before You Know This

A newer prostate cancer blood test is being promoted as 270% better than PSA, but what does that claim actually mean?In this episode of the Intellectual Medicine podcast, Dr. Stephen Petteruti examines the EpiSwitch PSE test, including its potential value, limitations, cost, and the research behind the widely cited 270% figure. He contrasts the test's yes-or-no risk assessment with PSA testing, emphasizing what he sees as PSA's key advantage: the ability to track changes over time.Dr. Petteruti also discusses how men and their physicians might approach an elevated PSA, the role of prostate MRI and biopsy in conventional care, and why he believes prostate cancer risk should be viewed as a long-term management challenge rather than a single diagnostic moment. He also raises questions about the sponsorship of the study behind the EpiSwitch claims while noting that industry involvement does not automatically invalidate the research.The episode concludes with a broader message: no test should be interpreted in isolation, and results should be considered in the context of a man's overall risk, health, and long-term monitoring strategy.Timestamps:(00:00) Is the EpiSwitch PSE really 270% better than PSA?(01:12) What the EpiSwitch PSE test can and can't tell you(02:09) The cost difference between EpiSwitch PSE and PSA(03:54) Why tracking PSA over time matters(05:46) Should you consider EpiSwitch after a high PSA?(07:17) Prostate cancer as a lifetime management challenge(08:08) The test versus how the test is interpreted(08:45) What an abnormal prostate MRI can mean(09:27) Looking at the study behind the "270% better" claim(10:20) The bottom line on EpiSwitch PSE versus PSAReferences:Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection- https://pubmed.ncbi.nlm.nih.gov/36765779/Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone, and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.📚 ResourcesDr. Petteruti Men's Vitality Grouphttps://www.intellectualmedicine.com/membershipFight Cancer Like a Manhttps://www.amazon.com/Fight-Cancer-Like-Man-Breakthrough/dp/B0GP6JHQTQDr. Petteruti's Newsletterhttps://drstephenpetteruti.substack.com/subscribePodcast Show Noteshttps://www.intellectualmedicine.com/podcast-notes🌐 Learn MoreDr. Stephen Petterutihttps://www.drstephenpetteruti.com/Intellectual Medicinehttps://www.intellectualmedicine.com/📱 Connect with Dr. PetterutiInstagramhttps://www.instagram.com/dr.stephenpetteruti/Facebookhttps://www.facebook.com/dr.stephenpetteruti🎧 Listen to the PodcastApple Podcastshttps://podcasts.apple.com/us/podcast/intellectual-medicine/id1458649409Spotifyhttps://open.spotify.com/show/3om1BQGP8f0hODZ6neWCd1#Overdiagnosis #ProstateHealth #MensVitality #ActiveSurveillanceDisclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.